º»¹®À¸·Î ¹Ù·Î°¡±â
(ÁÖ)½Å¿µ·ÎÆĸ¶
º´¿øÀü¹®¼îÇθô
ȸ»ç¼Ò°³
Á¦Ç°¼Ò°³
LAIS TABLETS
·ÎÆĸ¶ ¾Ë·¹¸£±â Áø´Ü¿ë ½Ã¾à
METACOLINA
EARVENT
ÀÚ·á½Ç
LAIS TABLETS ÀÚ·á½Ç
·ÎÆĸ¶¾Ë·¹¸£±â Áø´Ü½Ã¾à ÀÚ·á½Ç
¾Ë·¹¸£±â¶õ?
¾Ë·¹¸£±â¶õ?
¾Ë·¹¸£±â Ä¡·á¹æ¹ý
Home
ÀÚ·á½Ç
º´¿øÀü¹®¼îÇθô
ȸ»ç¼Ò°³
Á¦Ç°¼Ò°³
ÀÚ·á½Ç
¾Ë·¹¸£±â¶õ?
LAIS TABLETS ÀÚ·á½Ç
LAIS TABLETS ÀÚ·á½Ç
·ÎÆĸ¶¾Ë·¹¸£±â Áø´Ü½Ã¾à ÀÚ·á½Ç
LAIS TABLETS ÀÚ·á½Ç
2024. 04. 20. Àüü±Û: 41
31
27-Burastero_Mistrello_Paolucci,_clinical_and_immunological_correlates_of_pre-co-seasonal_sublingual
(ÁÖ)½Å¿µ
2019.08.28
11478
30
26-La Grutta, Evalutation of theantiinflammatory and Clinical effect of immunotherapy
(ÁÖ)½Å¿µ
2019.08.28
11480
29
22-Agostinis Tellarini CanonicaFalagiani, Safety of sublingual immunotherapy with a monomeric allerg
(ÁÖ)½Å¿µ
2019.08.28
11521
28
03-Caffarelli, Sensi, Cavagni,Preseasonal local allergoid immunotherapy to grass pollen in children
(ÁÖ)½Å¿µ
2019.08.28
11615
27
05-Palma Carlos SantosBranco-Ferreira et al. Clinical efficy and safety of preasonal sublingualimmun
(ÁÖ)½Å¿µ
2019.08.28
11616
26
23-Safety of tolerability of ultra-rush (20 minutes) sublingual immunotherapyin patients with allerg
(ÁÖ)½Å¿µ
2019.08.28
11773
25
04-Lombardi, Controlled study ofpreseasonal immunotherapy
(ÁÖ)½Å¿µ
2019.08.28
11793
24
32-SUBLINGUALALLERGOID IMMUNOTHERAPY A NEW 4-DAY INDUCTION PHASE_2010
(ÁÖ)½Å¿µ
2019.08.28
11860
23
¶óÀ̽ºÁ¤ ÀÓ»ó³í¹® ¸®½ºÆ®
(ÁÖ)½Å¿µ
2019.08.28
11936
22
33-Safety, tolerability and efficacy of sublingual_2010
(ÁÖ)½Å¿µ
2019.08.28
11940
[1]
2
[3]
[4]
[5]